Given that no evidence is currently available to clarify Sparfloxacin’ s potential as a photomutagen or photocarcinogen, it was agreed by the CPMP that the findings of studies investigating photomutagenicity and photocarcinogenicity must be provided to the CPMP by the end of 1996 at the latest.